AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00864136 — intervention group
Intervention type: DRUG
Intervention: Conventional medical treatment
Description: Women using anti-fibrinolytic agent for treatment of menorrhagia
Study NCT02957604 — intervention group
Intervention type: DRUG
Intervention: evolocumab
Description: Pregnant women exposed to evolocumab. Evolocumab is not administered in this non-interventional study.
Study NCT02972749 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Recommendations for lifestyle changes which have shown to reduce IOP. recommendations include: Moderate aerobic exercise, High fiber diet, sleeping with a head elevation and moderating caffeine intake. while continuing prescribed medical therapy.
Study NCT03241537 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity modulated radiotherapy
Study NCT00603382 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GW685698X
Description: GW685698X
Study NCT00603382 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo comparator
Study NCT00588081 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: QOL
Description: Those women who chose to have an interview will be scheduled for a 45 to 60 minute open-ended interview with a trained research assistant and sign consent at the time of the interview.
Study NCT00085098 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: filgrastim
Description: Given by infusion or injection
Study NCT00085098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboplatin
Description: Given IV over 1 hour
Study NCT00085098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Description: Given IV over 6 hours
Study NCT00085098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Description: Given IV over 1 hour
Study NCT00085098 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: etoposide
Description: Given IV over 2 hours
Study NCT00085098 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: Patients undergo radiotherapy 5 days a week
Study NCT01962545 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OAC alone
Description: Single APT with either aspirin or clopidogrel is discontinued in this arm.
Study NCT01859052 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Low carbohydrate diet
Description: Subjects will follow the Atkins for Life diet. They will be given the book and a study dietitian will guide them through the induction, ongoing weight loss, pre-maintenance, and lifetime maintenance phases.
Study NCT01859052 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Low calorie low fat diet
Description: The diet will be a nutritionally balanced, hypocaloric diet with a deficit of 750 kcal/day as guided by TEE. The goal is to match the calorie deficit to the low-CHO diet
Study NCT01859052 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: AHA diet recommendations
Description: given information in accordance with the diet and lifestyle recommendations of the American Heart Association.
Study NCT00597012 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial menisectomy
Description: Arthroscopic partial meniscectomy is a surgical procedure that is performed to remove a piece of torn cartilage in the knee joint. Incisions for arthroscopy are quite small, usually about 1 centimeter each. The torn meniscus can be removed using a number of different instruments, including small shavers and scissors.
Study NCT00597012 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard physical therapy
Description: Participants will undergo standard physical therapy that will include strengthening and stretching sessions one to three times a week for 8 weeks. This physical therapy regimen will have similar elements and goals as the postoperative intervention offered to Group 1 participants.
Study NCT00597012 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postoperative rehabilitative physical therapy
Description: This physical therapy is geared specifically toward rehabilitation after APM surgery.
Study NCT01855282 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Intervention
Description: Intervention participants attended up to 10 educational sessions teaching them about diabetes, and modifiable lifestyle factors (behaviors) to reduce the risk of diabetes by controlling weight. Sessions were conducted by Promotoras using culturally sensitive and appropriate materials and themes. Group activities and support were also emphasized. The control participants like the intervention were measured and interviewed before and again after the intervention sessions, but received no educational instruction or materials.
Study NCT01855282 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral Intervention
Description: Intervention participants attended up to 10 educational sessions teaching them about diabetes, and modifiable lifestyle factors (behaviors) to reduce the risk of diabetes by controlling weight. Sessions were conducted by Promotoras using culturally sensitive and appropriate materials and themes. Group activities and support were also emphasized. The control participants like the intervention were measured and interviewed before and again after the intervention sessions, but received no educational instruction or materials.
Study NCT02174575 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: Sevoflurane is administered during anesthesia in Sevoflurane group.
Study NCT02174575 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Desflurane
Description: Desflurane is administered during anesthesia in Desflurane group.
Study NCT00539032 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Menactra®: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
Description: 0.5 mL, Intramuscular
Study NCT00678470 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intralesional Alefacept
Description: Patients enrolled in this study will receive intralesional alefacept injections to a single psoriatic plaque at week 0. After a two week observation period, patients will receive 15 mg intramuscular alefacept for 12 weeks.
Study NCT03138694 — intervention group
Intervention type: OTHER
Intervention: BHCG monitoring
Description: Participants in the study will be invited to our outpatient clinic for BHCG monitoring including blood count and BHCG levels test and serial Transvaginal Ultrasound examination
Study NCT00006486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: carboxyamidotriazole
Description: Given orally
Study NCT00006486 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: placebo
Description: Given orally
Study NCT03212066 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Master Mind
Description: Master Mind is a 25-lesson elementary school mindfulness education substance abuse prevention program. Each lesson takes approximately 15 minutes and is designed to be taught by trained teachers every day for 5 weeks.
Study NCT00520403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interferon alfa-2a
Description: 3 MioIU sc escalating to 18 MioIU sc, 3 times weekly
Study NCT00520403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinblastine
Description: 0.1mg/kg iv every 3 weeks
Study NCT02591797 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: inferior alveolar and lingual nerve block procedure
Description: The needle is inserted laterally to the pterygomandibular pit at its deepest point without noticing any resistance. In children the positioning of the syringe must be perpendicular, between the canine and the first molar on the opposite side and puncture is performed slightly below the occlusal plane. It was initially deposited 2/3 anesthetic carpule solution and then the needle is slightly recede depositing there the remaining third of anesthetic solution.~The application of anesthesia shall be in accordance with the following guidelines:~1. Topical Anesthetic: Benzocaine 20% (Hurricaine, Clarben Laboratories SA, Madrid, Spain).~2. Dental Needle: short needles (21mm/30g) (Octoplus, Clarben Laboratories SA, Madrid, Spain)~3. anesthetic: lidocaine hydrochloride 2% with epinephrine 1: 100,000 (2% XILOCAINE, Dentsply, Spain).~4. Syringe: carpule syringe-conventional harpoon with suction system.
Study NCT02591797 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: inferior alveolar and lingual nerve block procedure
Description: The needle is inserted laterally to the pterygomandibular pit at its deepest point without noticing any resistance. In children the positioning of the syringe must be perpendicular, between the canine and the first molar on the opposite side and puncture is performed slightly below the occlusal plane. It was initially deposited 2/3 anesthetic carpule solution and then the needle is slightly recede depositing there the remaining third of anesthetic solution.~The application of anesthesia shall be in accordance with the following guidelines:~1. Topical Anesthetic: Benzocaine 20% (Hurricaine, Clarben Laboratories SA, Madrid, Spain).~2. Dental Needle: short needles (21mm/30g) (Octoplus, Clarben Laboratories SA, Madrid, Spain)~3. anesthetic: lidocaine hydrochloride 2% with epinephrine 1: 100,000 (2% XILOCAINE, Dentsply, Spain).~4. Syringe: carpule syringe-conventional harpoon with suction system.
Study NCT03858283 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Health Care (MBHC) Program
Description: Mindfulness Based Health Care (MBHC) Program for Caregivers of Alzheimer's Disease Patients. The duration of this group was 8 weeks. The program included one session per week, with each session lasting 1 hour and 30 minutes
Study NCT00055679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cyclophosphamide
Study NCT00055679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: cyclophosphamide
Study NCT00055679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epirubicin hydrochloride
Study NCT00055679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: epirubicin hydrochloride
Study NCT00055679 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fluorouracil
Study NCT00055679 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluorouracil
Study NCT02532114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enzalutamide
Description: Given PO
Study NCT02532114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT02532114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Niclosamide
Description: Given PO
Study NCT02532114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT05006846 — intervention group
Intervention type: OTHER
Intervention: Opioid Addiction Recovery Support Software Platform
Description: OARS (Opioid Addiction Recovery Support) is used by providers of MAT programs to improve insight into a patient's recovery progress while promoting ownership and adherence to treatment plans. OARS also provides extensive tools to support patients with recovery from Opioid Use Disorder.
Study NCT04239950 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04239950 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ethyl Icosapentate
Description: Ethyl Icosapentate
Study NCT02444975 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mineral water
Description: 1.5L/day of water on top of the normal fluid intake for 1 year
Study NCT02444975 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coaching program
Description: Coaching program to support increased water intake
Study NCT02444975 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT04140240 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: intervention group
Description: Parallel Assignment a experimental design with pre test and post test
Study NCT03146975 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal treatment
Description: Quadrant-wise ultrasonic debridement followed by manual scaling and root planing under local anesthesia provided in weekly sections. Oral hygiene instructions.
Study NCT04521114 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered subcutaneously every week for 13 weeks.
Study NCT04521114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leronlimab 700 mg
Description: 700 mg leronlimab will be administered subcutaneously every week for 13 weeks.
Study NCT02122549 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HWD1000
Description: Wearable cardioverter-defibrillator designed for inpatient use
Study NCT03364478 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: DML group
Description: The group underwent laparoscopic right hemicolectomy with dorsal and medial hybrid approach.
Study NCT04521114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leronlimab 350 mg
Description: 350 mg leronlimab will be administered subcutaneously every week for 13 weeks.
Study NCT03364478 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: MLA group
Description: The group underwent laparoscopic right hemicolectomy with traditional medial-to-lateral approach.
Study NCT01828398 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: real-tDCS + UE robot-assisted therapy
Study NCT01828398 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham-tDCS + UE robot-assisted therapy
Study NCT02603861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3154207
Description: LY3154207 administered orally.
Study NCT02603861 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo administered orally.
Study NCT02603861 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Modafinil
Description: Modafinil administered orally.
Study NCT01543906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QLT091001
Description: oral QLT091001 administered once daily for 7 days
Study NCT01932983 — intervention group
Intervention type: DEVICE
Intervention: Train of four test
Description: TOF test includes stimulation of peripheral nerve of upper extremity, ulnar nerve in this study. Two methods of interpretation are included, visual which uses anesthesiologist TOF device, and quantitative uses intraoperative neurophysiologic monitoring device, both devices are in routine clinical practice use. Different interpretation of muscle contractions are followed, by quantitative method and visual method. Visual evaluates number of twitches and determines the degree of neuromuclular block and percent of blocked acetylcholine receptors. Quantitative method record muscle contraction by using EMG, presents each twitch as amplitude, caluculate peak to peak value, and provide numerical value and difference for each twitch.
Study NCT01751165 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Herpes zoster vaccine GSK1437173A
Description: 2 doses administered intramuscularly (IM) in the deltoid region of the non-dominant arm.
Study NCT05082662 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diclofenac Potassium coated tablet (50 mg Diclofenac Potassium)
Description: One Diclofenac tablet was administered orally.
Study NCT05082662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac Potassium coated tablet (50 mg Diclofenac Potassium)
Description: One Diclofenac tablet was administered orally.
Study NCT05082662 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cataflam® 50 coated tablet
Description: One Diclofenac tablet was administered orally.
Study NCT05082662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cataflam® 50 coated tablet
Description: One Diclofenac tablet was administered orally.
Study NCT04095598 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Comparative Ankle Tomography with Stress Maneuvers
Description: All diagnostic imaging exams and FAAM questionnaire will be applied in a standard way in both groups.
Study NCT02982096 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cellutome Device
Description: Use of FDA approved Cellutome treatment on burn wounds
Study NCT02982096 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standard of Care
Description: Acellular burn wound management
Study NCT02694588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infliximab
Description: HD-endoscopy, CLE, endoscopic ultrasound after application of TNF alpha antibody
Study NCT02694588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vedolizumab
Description: HD-endoscopy, CLE, endoscopic ultrasound after application of Anti-Integrin antibody
Study NCT02223871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-451840:
Description: ACT-451840 500 mg was provided in 100 mL amber glass bottles formulated as a powder for oral suspension. The ACT-451840 suspension was prepared extemporaneously by addition of 25 mL of water and administered orally under fed condition.
Study NCT02223871 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plasmodium falciparum-infected human erythrocytes:
Description: Each participant was inoculated on Day 0 with approximately 1,800 viable Plasmodium falciparum-infected human erythrocytes administered intravenously.
Study NCT02223871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artemether 20 mg and lumefantrine 120mg combination tablet:
Description: Rescue treatment to ensure clearance of Plasmodium falciparum comprising six doses of four tablets (total course of 24 tablets) given over a period of 60 hours. Each dose of tablets administered orally was immediately followed by food or drinks rich in fat (e.g., milk).
Study NCT02223871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Primaquine:
Description: Rescue treatment to ensure clearance of Plasmodium falciparum, to be taken as a single oral 45 mg dose with food only if gametocytes were identified after administration of Riamet® rescue medication.
Study NCT00463580 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Infliximab
Description: Participants will receive three infusions 5mg/kg of infliximab (at Baseline, Week 2 and Week 6)
Study NCT00463580 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive three infusions of a placebo (at Baseline, Week 2 and Week 6)
Study NCT04287634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Segmental Mobilization
Description: Hot fermentation =10 minutes Soft tissue mobilization =5 minutes Targeted segmental mobilization= 3 sets of 10 repetitions Home plan exercise= cervical muscles stretching, postural care.
Study NCT04287634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Entire Spine Mobilization
Description: Hot fermentation=10 minutes Soft tissue mobilization=5 minutes Entire spine mobilization =3 sets of 10 repetitions Home plan exercises=cervical muscles stretches, postural care.
Study NCT03313583 — intervention group
Intervention type: PROCEDURE
Intervention: Transfusion of blood products
Study NCT01020942 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electroacupuncture stimulation
Description: According to the theory of traditional Chinese medicine, bilateral Neiguan (PC 6) acupoints were chosen and identified according to traditional anatomical localizations. Once insertion of original needles was made at the acupoints, the needle was stimulated electrically with the intensity of 2-6 mA and frequency of 2/30 Hz using the Electronic Acupuncture Treatment Instrument until the patient felt the so-called 'Teh Chi' sensation of heaviness, numbness and swelling. The pretreatment was individualized based on patients sex, age, weight and felt and given 1 time per day for 5 consecutive days before the heart valve replacement surgery．
Study NCT01020942 — intervention group
Intervention type: PROCEDURE
Group type: NO_INTERVENTION
Intervention: No intervention
Description: The control patients were only placed needles at the bilateral Neiguan (PC 6)acupoints without electric stimulus.
Study NCT04205214 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrative Cognitive Behavioural Therapy
Description: This intervention involves the psychological intervention of Cognitive Behavioural Therapy. This intervention also includes third wave psychological interventions of Mindfulness and Narrative Therapy which has been found to be helpful for people with chronic health conditions and chronic skin conditions.
Study NCT00647998 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Description: Patients will receive one IV injection of Darbepoetin alfa at doses ranging from 1mcg/kg to 6.5 mcg/kg prior to surgery
Study NCT00647998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard care
Study NCT00647998 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard care
Study NCT02107547 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biceps tenodesis
Description: A biceps tenodesis involves cutting the tendon within the shoulder joint and reattached further down the arm.
Study NCT02107547 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Labral repair
Description: Repair of a Superior Labrum Anterior and Posterior lesion involves placing small anchors in the glenoid to re-attach the torn labrum.